Radboudumc is advancing theranostics, a personalized treatment approach combining diagnostics and therapy for cancers like prostate cancer, led by nuclear medicine specialist Daniela Oprea-Lager. She emphasizes the benefits of early radionuclide therapies to manage disease while preserving patients' quality of life. Oprea-Lager is also exploring combining radioactive treatments with chemotherapy and radiotherapy for better outcomes. Recent findings indicate that PSMA PET scans are more effective than traditional bone scans for staging prostate cancer, highlighting the importance of precise tumor characterization for radiotherapy. Oprea-Lager aims to establish Radboudumc as a leading center in theranostics and has assumed a professorship role starting May 1, 2025.
Mon, 26 May 2025 08:02:19 GMT | healthcare-in-europe.com